Find Practice Guidelines
The HIV Medicine Association is an organization of medical professionals who practice HIV medicine. We represent the interests of our patients by promoting quality in HIV care and by advocating for policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice.
IDSA Engages House Subcommittee Ahead of Hearing on Antibiotic Resistance (PDF)
In advance of a hearing on federal efforts to address antibiotic resistance, IDSA wrote to leaders of the Subcommittee to urge support for implementation of the National Action Plan for Combating Antibiotic-Resistance Bacteria. The letter placed particular emphasis on antibiotic stewardship, incentives to spur R&D, ID workforce challenges, and the need for increased funding for federal AR programs.
IDSA Zika Vote Statement (PDF)
IDSA urges Congress to pass the strongest emergency bill possible to combat Zika and to reject efforts to fund the Zika response at the expense of equally critical health funding.
IDSA, ASM, and PASCV Letter to FDA on LDTs (PDF)
IDSA, ASM and the Pan-American Society for Clinical Virology urge FDA to consider the vital role of lab developed tests in rapidly diagnosing and appropriately treating infectious diseases.
PACCARB Press Release
Recommendations from the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria reflect IDSA input.
IDSA & HIVMA Engage HHS on Drug Pricing and Innovation
IDSA and HIVMA wrote to HHS Secretary Burwell to distinguish efforts to incentivize development of desperately needed new drugs from recent actions to significantly increase the costs of decades old drugs.
IDSA Provides Testimony to House and Senate Spending Panels on 2017 Budget (PDF)
IDSA provided testimony to the House and Senate subcommittees that oversee spending on health programs. The statement largely focused on federal efforts to combat the Zika virus and antimicrobial resistance.
IDSA Writes to Senate Aging Committee Ahead of Hearing on Drug Pricing Spikes
IDSA wrote to the Senate Special Committee on Aging ahead of a planned hearing on recent drug price spikes. The IDSA letter distinguished efforts to incentivize development of desperately needed new drugs from recent actions to significantly increase the costs of decades old drugs.
IDSA Leads Stakeholders In Support of R&D Tax Credit for Antibiotics and Rapid Diagnostics
Forty groups representing providers, patients, public health and industry joined a letter – circulated by IDSA – supporting the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539.
1 of 8
Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
Updated CDC Clinical Zika Recommendations: July 25, 2016
CDC assisting Utah investigation of Zika virus infection apparently not linked to travel
FDA announces voluntary nationwide recall of oral liquid docusate sodium manufactured by PharmaTech and distributed by Rugby Laboratories
CDC Recommendations for Subsequent Zika IgM Antibody Testing
Best Practices for Using PCR to Diagnose Haemophilus influenzae and Neisseria meningitidis and Identify Serotype or Serogroup
Alert to U.S. Healthcare Facilities: First mcr-1 Gene in E. coli Bacteria found in a Human in the United States
Stӧckert 3T Heater-Cooler System by Sorin Group Deustchland GmbH: Safety Communication - Reports of Mycobacterium Chimaera Infections
>> Read More
Early diagnosis ensures the best management and reduces unneeded tests and treatment, note updated guidelines released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Disease.
HCVguidelines.org, a website developed by the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) to provide up-to-date guidance on the treatment of hepatitis C (HCV) has updated several sections of the website based on newly available therapies and data.
If guidelines are followed, pre-exposure prophylaxis can greatly reduce HIV incidence over the next 10 years in the U.S. among men who have sex with men, CID study finds.
Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) - which account for 20 to 25 percent of hospital-acquired infections - should be treated with shorter courses of antibiotics than they typically are, according to new guidelines released by the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) and published in the journal Clinical Infectious Diseases.
>>Read More From the PresidentNew IDSA Guideline on Diagnosis and Treatment of AspergillosisOPAT Handbook Now Available in Interactive, Digital FormatDon't Miss the Meeting Everyone will be Talking about at IDWeek 2016!
New therapies are improving care, but early diagnosis remains critical in the effective treatment of invasive aspergillosis, a potentially deadly fungal infection, according to new guidelines released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases.
From the PresidentIDSA Foundation Offers Three Research Awards in 2016Accessing the Members-Only Section of the IDSA Website - Action Needed!Senate Bill Threatens Medical Research at the Department of DefenseJournal Club
1 of 7
| IDSA | Contact Us
© Copyright HIVMA 2016 HIV Medicine Association